why choose us

First received: September 21, 2022

Clinical Trial: Effects of Acute and Chronic Empagliflozin Heart Failure

Study Status: Completed

Recruit Status: RECRUITING

Condition: Heart Failure

Study Type: INTERVENTIONAL


Official Title: Renal Mechanistic Effects of Acute and Chronic Empagliflozin in Heart Failure

Brief Summary: This is a 60-patient randomized, double-blind, placebo-controlled mechanistic study to understand the utility of empagliflozin in worsening heart failure (HF) patients with or without diabetes.Participants will be randomized to empagliflozin or placebo for 6 weeks, followed by a crossover of placebo patients to active therapy at 6 weeks-12 weeks.

Read more